Clinical Trial Update: Ureteral Stent-related Pain and Mirabegron (SPAM) Trial [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on ureteral stent-related pain and mirabegron (SPAM) completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nephrolithiasis

Drugs mentioned

• Mirabegron (mirabegron)

Snippet

Sponsor: Nova Scotia Health Authority | Conditions: Nephrolithiasis | Phase 4 | Status: COMPLETED